The Solubility Company

What The Solubility Company does

The Solubility Company is a Helsinki, Finland-based pharmaceutical technology company founded in 2018 that develops AI-enabled Single Particle Analysis (SPA®) for pharmaceutical solubility testing and formulation development. Operating as a Finnish private limited company (Oy) with 1-10 employees, the company targets pharmaceutical clients seeking improved characterization of drug solubility profiles during development.

The company's core technology is its proprietary SPA® platform, which combines single-particle-level analytical methods with AI-enabled data processing to characterize solubility behavior. SPA® is a registered trademark, and the platform is offered both as an in-house analytical service and via licensing to qualified partners. The technology addresses a well-known bottleneck in pharmaceutical R&D: the difficulty of accurately measuring and predicting solubility, which influences bioavailability, formulation choice, and development timelines for oral and other dosage forms.

The Solubility Company operates a dual commercial model. First, it delivers data-driven formulation services to pharmaceutical clients using the SPA® platform. Second, it licenses the SPA® platform to qualified partners, with Microsize LLC serving as its first US licensee under a 2025 arrangement that also provides a US lab presence in Quakertown, Pennsylvania. The company has additionally established a cloud lab integration partnership with Persist AI. Geographic footprint currently consists of the Helsinki headquarters and the Microsize-operated Quakertown lab, with no other disclosed offices or full-time commercial presence outside Finland.

Name

The Solubility Company

Legal name

The Solubility Company Oy

Website

https://thesolubilitycompany.com

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

1–10 employees

Short description

The Solubility Company is a Helsinki-based pharmaceutical technology firm that provides AI-enabled Single Particle Analysis (SPA®) for drug solubility testing and formulation services to pharmaceutical clients.

Ownership category

akta.pro rank

Product category

Pharmaceutical Solubility Testing Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Analytical Laboratory Instrument Manufacturing (334516)

SIC

Laboratory Analytical Instruments (3826), Services-Testing Laboratories (8734)

akta.pro primary industry

AI/ML Platforms for Drug Discovery & Experiment Optimization (HLAGAJAO)

akta.pro secondary industry

Liquid Handling & Laboratory Automation (Pipettes, Robots, Workstations) (HLAGAIAD)

Keywords

• Pharmaceutical solubility testing
• Drug formulation development
• Single particle analysis
• Preclinical lab services
• AI drug discovery

Headquarters

HQ city

Helsinki

HQ country

Finland

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Technology or R&D, Personnel, Operations, Infrastructure, Marketing or Sales

Revenue model

1. Platform Licensing: Direct licensing of SPA platform to global partners, with Microsize LLC as first US licensee. Enables technology adoption and generates licensing fees from platform access.
2. Data-Driven Formulation Services: Provides solubility measurement data and AI-driven formulation insights through cloud lab integration, enabling early identification of optimal delivery vehicles for pharma clients.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels2 records

Core offering

The Solubility Company provides pharmaceutical solubility measurement services powered by its proprietary AI-enabled Single Particle Analysis (SPA®) technology. The platform combines ultra-low sample solubility measurement with automated wet-lab workflows and predictive AI models, generating thousands of data points at milligram scale to accelerate drug formulation development. Offerings are delivered via direct platform licensing, the company's own solubility laboratories, and integration into partner cloud lab platforms.

Product overview

The Solubility Company offers the SPA® (Single Particle Analysis) platform as its core product, an AI-enabled technology for pharmaceutical solubility testing and measurement. The company operates solubility laboratories and provides direct licensing of its SPA® platform. The offering combines ultra-low sample solubility measurement with automated wet-lab processes and predictive AI models, enabling pharmaceutical clients to accelerate drug formulation development. The company has expanded globally through licensing partnerships, with Microsize LLC serving as the first US licensee, and has integrated its technology into Persist AI's Cloud Lab platform.

Differentiator

Problem solved

Functional benefit

Brands

• SPA™: Single Particle Analysis technology - AI-enabled solubility measurement technology for pharmaceutical testing
• SPA®

Products and services

• SPA® (Single Particle Analysis) Platform AI-enabled Single Particle Analysis technology platform for pharmaceutical solubility testing and measurement, combining ultra-low sample solubility measurement with automated wet-lab processes and predictive AI models to generate thousands of data points at milligram scale for drug formulation development. Offered via direct licensing to partners and accessed through cloud lab platforms.
• AI-Enabled SPA Technology Laboratory (Solubility Lab) Pharmaceutical solubility testing laboratory service utilizing AI-enabled Single Particle Analysis (SPA) technology to improve measurement accuracy and accelerate drug development for pharmaceutical clients in the US market, operated from the company's lab in Quakertown, Pennsylvania.

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability4 records

Feature2 records

Partnerships

Two partnerships are on record, tiered core.

• Persist AIcoreStrategic or Co-development Partner · 13 May 2026Strategic collaboration launched May 13, 2026 to deploy the first fully automated SPA platform combining ultra-low sample solubility measurement with automated wet-lab and predictive AI models. Partnership integrates technology into Persist AI's Cloud Lab for cloud laboratory users, enabling early identification of optimal delivery vehicles months faster than traditional approaches.
• Microsize LLCcoreOEM/ Whitelabel/ Licensing Partner · 16 October 2025Microsize LLC became the first US licensee for The Solubility Company's SPA platform as part of global expansion strategy. Licensing model accelerates technological adoption and meets rising demand for high-quality solubility data in drug discovery.

Scale indicators2 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Pion Inc. Pion is a specialist in pharmaceutical solubility and permeability measurement services (e.g., Dissolution, Rainbow Monkey, SGA). It directly overlaps with The Solubility Company's core offering of solubility testing for formulation, serving the same pharma R&D customers.
• Sirius Analytical: Sirius Analytical provides physicochemical profiling, pKa, solubility, and dissolution services for drug discovery. It is a direct peer in the small-molecule solubility measurement market that The Solubility Company targets.
• Nanoform Finland Oyj: Nanoform is a Finnish nanoparticle engineering company that improves drug solubility and bioavailability via its CESS® technology. It is a Nordic peer applying proprietary particle-level science to the same pharmaceutical solubility/formulation problem The Solubility Company addresses.
• Avantium Pharma Services: Avantium offers solid-form and crystallization R&D services for pharma, addressing the same data scarcity in physical chemistry that The Solubility Company targets with SPA® measurement data.
• Crystallics Pharma: Crystallics is a specialist CRO in solid-state and crystallization services for pharma, working on solubility and polymorph challenges — directly comparable to The Solubility Company's single-particle solubility measurement focus.

Broad incumbents

• Charles River Laboratories: Charles River is a large CRO offering formulation, solid-state, and preclinical services including solubility characterization. It competes broadly for the same pharma formulation spend but does not specialize in SPA-style single-particle solubility.
• Eurofins Scientific: Eurofins operates a global network of pharma testing laboratories including physicochemical and solubility characterization. It is an incumbent alternative to The Solubility Company's specialized services, with much broader reach but less depth in single-particle analysis.
• Thermo Fisher Scientific: Thermo Fisher supplies analytical instruments and CDMO services for pharma, including chromatography and dissolution tools used in solubility workflows. It represents the incumbent instrument and services supplier against which The Solubility Company's platform competes.

Emerging players

• Recursion Pharmaceuticals: Recursion applies AI/ML and high-throughput lab automation to drug discovery, similar to how The Solubility Company combines automation and AI for solubility/formulation. It is an emerging peer in AI-driven pharma experimentation rather than direct formulation competition.
• Insilico Medicine: Insilico uses AI platforms across drug discovery and development, intersecting with The Solubility Company's positioning of SPA® as an AI-enabled drug formulation tool. It is a partial-overlap emerging player rather than a direct competitor.

Market position

Strengths1 record

Weaknesses1 record

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about The Solubility Company